FDA Approval: AMBELVIST (GADOQUATRANE) — Type 1 - New Molecular Entity
Policy FDA-NDA219627 · Radiology
HighAmbelvist (Gadoquatrane) is approved for intravenous administration, indicating that billing will follow the Part B pathway. As it is designated as an orphan drug, it may qualify for special considera
View alertLCD L33459: Computerized Axial Tomography (CT), Thorax — Palmetto GBA
Policy LCD-L33459 · Radiology
HighThe finalized LCD L33459 outlines billing guidelines for Computerized Axial Tomography (CT) of the thorax, effective 06/11/2026. Providers in the impacted states should review the guidelines thoroughl
View alertProposed LCD DL40276: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities — Novitas
Policy LCD-DL40276 · Radiology
HighThe proposed LCD for Non-invasive Arterial Duplex Ultrasound may lead to an increase in imaging services for assessing vascular health, impacting reimbursement rates positively for practices that perf
View alertProposed LCD DL40289: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities — First Coast
Policy LCD-DL40289 · Radiology
HighThe proposed LCD for non-invasive arterial duplex ultrasound of the upper and lower extremities may lead to supports compliance with updated rates for providers in the relevant specialties. This could i
View alert